Posted by Michael Wonder on 31 Aug 2020
Schedule of Pharmaceutical Benefits - 1 September 2020 update
1 September 2020 - The September 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The September issue of the Schedule includes a few new/revised listings:
- Acalabrutinib (Calquence) - new medicine
- Methylphenidate hydrochloride (Ritalin LA) - new strength
- Pembrolizumab (Keytruda) - new indication x 2
